## LH: Labcorp Holdings Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -3.1% below STRENGTH zone (4.0-10.0%); PEG 1.85 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($244.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Labcorp Holdings Inc. $LH Shares Sold by Wedge Capital Management L L P NC**
- Source: MarketBeat | 20251221T123520 | Somewhat-Bullish | Relevance: 100%
- Wedge Capital Management L.L.P. NC significantly reduced its stake in Labcorp Holdings Inc. (NYSE:LH) by 19.3% in the third quarter of 2025, selling 22,859 shares and retaining 95,783 shares valued at approximately $27.5 million. Concurrently, company insiders, including CEO Adam H. Schechter and Director Richelle P. Parham, also reduced their holdings. Despite these sales, Labcorp has received more positive sentiment from analysts, with several firms raising price targets, leading to an average "Moderate Buy" rating and a price target of $299.08.

**2. Assenagon Asset Management S.A. Trims Position in Labcorp Holdings Inc. $LH**
- Source: MarketBeat | 20251221T090834 | Somewhat-Bullish | Relevance: 96%
- Assenagon Asset Management S.A. significantly reduced its stake in Labcorp Holdings Inc. (NYSE:LH) by 69.8% in the third quarter, while company insiders also sold shares. Despite these sales, analyst sentiment remains largely positive, with a "Moderate Buy" rating and an average target price of $299.08. Labcorp has also announced a quarterly dividend and provided robust FY2025 earnings guidance.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 5 ($3.37M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-0.7%)
- Blackrock Inc.: 9.8% (-10.3%)
- State Street Corpora: 4.6% (-0.8%)
- Victory Capital Mana: 3.2% (+20.0%)
- JPMORGAN CHASE & CO: 2.6% (+64.8%)

### Key Risks

1. Insider selling cluster: $3.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.85 elevated, pricing in significant growth expectations. Insider selling cluster ($3.4M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.2B |
| Beta | 0.96 |
| 52W Range | $209.38 - $293.72 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.85 |
| Forward P/E | 14.6 |
| Current P/E | 15.6 |
| YoY Growth | 7.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.9% to -3.1% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.1pp (needs >4.0% for momentum thesis). Below SMA200 (0.99x), long-term trend not supportive. MACD histogram bearish (-0.89), momentum weakening. RSI neutral at 41. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: +F0N (Breakout).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.14% (CS: 17) | Weak |
| RSI_14 | 40.9 | Neutral |
| MACD Histogram | -0.89 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.962x | Below |
| vs SMA200 | 0.990x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $255.05
- **Stop Loss:** $244.69 (4.1% risk)
- **Target:** $265.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 115
- **Position Value:** $29,330.75
- **Portfolio %:** 29.33%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-05 (Est: $3.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.14 | $4.18 | +1.0% |
| 2025Q2 | $4.18 | $4.35 | +4.1% |
| 2025Q1 | $3.73 | $3.84 | +2.8% |
| 2024Q4 | $3.39 | $3.45 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*